Shenzhen Huishan Biotechnology Co., Ltd.

This early-stage trial tests a new stem cell treatment (HS_SW01) for people with systemic sclerosis, a disease that causes skin hardening and organ damage. The main goal is to see if the treatment is safe and tolerable in 21 adults aged 18-65. Researchers will also check if it im…

This early-stage trial tests a new stem cell treatment (HS_SW01) for people with ankylosing spondylitis, a condition that causes spine inflammation and stiffness. The study will enroll 18 adults aged 18-65 to check if the treatment is safe and helps reduce symptoms. Participants …

This early-phase trial tests a stem cell injection (HS_SW01) in 21 women with primary ovarian insufficiency (POI), a condition where the ovaries stop working before age 40. The main goal is to check safety and see if the treatment can improve hormone levels related to ovarian fun…